COMPASS Pathways plc
15.17USD
+1.1300 (+8.05%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.33▲ | $-0.35 | 0 | 1 |
| Next quarter | $-0.39▲ | $-0.41 | 0 | 1 |
| Current year | $-1.51▼ | $-1 | 0 | 0 |
| Next year | $-1.43▼ | $-1.06 | 1 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.34 | $-0.36 | -0.02 (-6.6%) |
| 2026-03-31 | $-0.32 | $-0.31 | +0.01 (+3.2%) |
| 2025-12-31 | $-0.39 | $-0.61 | -0.22 (-55.5%) |
| 2025-09-30 | $-0.41 | $-0.38 | +0.02 (+5.3%) |
86 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $70 $65 | Aug 7, 2026 |
| Morgan Stanley | Maintained | Overweight | $17 $18 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $22 $21 | Aug 6, 2026 |
| B. Riley Securities | Maintained | Buy | $17 $22 | Aug 6, 2026 |
| Wells Fargo | Initiated | Equal-Weight | $13 | Jul 27, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $70 | Jul 8, 2026 |
| Evercore ISI Group | Upgraded from In-Line | Outperform | $8 $21 | Jul 8, 2026 |
| Stifel | Maintained | Buy | $14 $21 | Jul 8, 2026 |
| Morgan Stanley | Reiterated | Overweight | $17 | Jul 7, 2026 |
| Oppenheimer | Reiterated | Outperform | $20 | Jul 7, 2026 |
| BTIG | Maintained | Buy | $14 $25 | Jul 7, 2026 |
| Canaccord Genuity | Maintained | Buy | $18 $20 | Jun 26, 2026 |
| Maxim Group | Maintained | Buy | $12 $20 | May 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $16 $17 | May 14, 2026 |
| RBC Capital | Maintained | Outperform | $21 $22 | May 14, 2026 |
| BTIG | Reiterated | Buy | $14 | May 13, 2026 |
| Jefferies | Initiated | Buy | $18 | May 4, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $70 | Apr 28, 2026 |
| B. Riley Securities | Initiated | Buy | $17 | Apr 24, 2026 |
| BTIG | Reiterated | Buy | $14 | Apr 20, 2026 |
| Canaccord Genuity | Maintained | Buy | $20 $18 | Mar 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $18 $16 | Mar 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40 $70 | Mar 2, 2026 |
| Canaccord Genuity | Maintained | Buy | $15 $20 | Feb 18, 2026 |
| Morgan Stanley | Maintained | Overweight | $11 $18 | Feb 18, 2026 |
6 filings from 5 insiders · 0 buy / 0 sell over 6m
Officers and directors of CMPS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| NATH KABIRChief Executive Officer | Grant | 175.0k | — | — | Mar 26, 2026 |
| LOXAM TERIChief Financial Officer | Grant | 75.0k | — | — | Mar 26, 2026 |
| LOXAM TERIChief Financial Officer | Grant | 25.0k | — | — | Mar 11, 2025 |
| MALIEVSKAIA EKATERINABeneficial Owner of more than 10% of a Class of Security | Sell | 1.55M | $6.43 | $9.99M | Oct 24, 2024 |
| GOLDSMITH GEORGE JAYBeneficial Owner of more than 10% of a Class of Security | Sell | 776.6k | $6.43 | $4.99M | Oct 24, 2024 |
| ATAI LIFE SCIENCES NVBeneficial Owner of more than 10% of a Class of Security | Sellindirect | 2.66M | $6.05 | $16.09M | Sep 26, 2024 |
No analyst notes on CMPS yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 12 | 1 | 0 | 0 | Buy1.88 |
| 1 mo ago | 3 | 12 | 1 | 0 | 0 | Buy1.88 |
| 2 mo ago | 3 | 11 | 1 | 0 | 0 | Buy1.87 |